World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
118
Citations
50312
World Ranking
4067
National Ranking
117

Overview

Eugenio Mercuri is affiliated with the Catholic University of the Sacred Heart in Italy. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a strong focus on Molecular Biology and Genetics within these broader disciplines.

The scientist's research interests emphasize Neurogenetic and Muscular Disorders, having contributed extensively to topics including Muscle Physiology and Disorders, RNA modifications and cancer, Congenital Anomalies and Fetal Surgery, Cardiomyopathy and Myosin Studies, RNA Research and Splicing, and Muscle activation and electromyography studies.

Among their recent publications are several notable papers:

  • Spinal muscular atrophy, 2022, Nature Reviews Disease Primers
  • Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial, 2021, The Lancet Neurology
  • Duchenne muscular dystrophy, 2021, Nature Reviews Disease Primers
  • Risdiplam in Type 1 Spinal Muscular Atrophy, 2021, New England Journal of Medicine
  • Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy, 2020, Neurology

The scientist has frequently published in venues such as:

  • Neuromuscular Disorders (104 publications)
  • Neurology (35 publications)
  • Journal of Neuromuscular Diseases (19 publications)
  • PLoS ONE (13 publications)
  • European Journal of Pediatrics (13 publications)

Collaborations have been a significant aspect of their work, with frequent coauthors including:

  • Marika Pane (126 coauthored publications)
  • Giorgia Coratti (94 publications)
  • Francesco Muntoni (87 publications)
  • Valeria Sansone (73 publications)
  • Adele D'Amico (73 publications)

Best Publications

  • Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy

    Richard S. Finkel;Eugenio Mercuri;Basil T. Darras;Anne M. Connolly

  • Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy

    Eugenio Mercuri;Basil T. Darras;Claudia A. Chiriboga;John W. Day

  • Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care.

    Eugenio Mercuri;Richard S Finkel;Francesco Muntoni;Brunhilde Wirth

  • Duchenne muscular dystrophy.

    Dongsheng Duan;Nathalie Goemans;Shin'ichi Takeda;Eugenio Mercuri

  • Origin and timing of brain lesions in term infants with neonatal encephalopathy

    Frances Cowan;Mary Rutherford;Floris Groenendaal;Paula Eken

  • Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan.

    Martin Brockington;Derek J. Blake;Paola Prandini;Susan C. Brown

  • Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics.

    Richard S. Finkel;Eugenio Mercuri;Oscar H. Meyer;Anita K. Simonds

  • Spinal muscular atrophy.

    Adele D'Amico;Eugenio Maria Mercuri;Francesco Danilo Tiziano;E. Bertini

  • Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy.

    Jerry R. Mendell;Nathalie Goemans;Linda P. Lowes;Lindsay N. Alfano

  • Clinical and molecular genetic spectrum of autosomal dominant Emery‐Dreifuss muscular dystrophy due to mutations of the lamin A/C gene

    Bonne G;Mercuri E;Muchir A;Urtizberea A

  • Ataluren treatment of patients with nonsense mutation dystrophinopathy

    Katharine Bushby;Richard Finkel;Brenda Wong;Richard Barohn

  • Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan.

    Caroline Godfrey;Emma Clement;Rachael Mein;Martin Brockington

  • Abnormal magnetic resonance signal in the internal capsule predicts poor neurodevelopmental outcome in infants with hypoxic-ischemic encephalopathy

    M. A. Rutherford;J. M. Pennock;S. J. Counsell;E. Mercuri

  • Muscle MRI in inherited neuromuscular disorders: past, present, and future.

    Eugenio Mercuri;Eugenio Mercuri;Anna Pichiecchio;Joanna Allsop;Sonia Messina

  • Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

    Craig M McDonald;Craig Campbell;Ricardo Erazo Torricelli;Richard S Finkel;Richard S Finkel

  • Childhood spinal muscular atrophy: controversies and challenges

    Eugenio Mercuri;Enrico Bertini;Susan T Iannaccone

  • Optimality score for the neurologic examination of the infant at 12 and 18 months of age

    Leena Haataja;Eugenio Mercuri;Rivka Regev;Frances Cowan

  • Early Prognostic Indicators of Outcome in Infants With Neonatal Cerebral Infarction: A Clinical, Electroencephalogram, and Magnetic Resonance Imaging Study

    Eugenio Mercuri;Mary Rutherford;Frances Cowan;Jackie Pennock

  • The Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND): test development and reliability.

    A.M. Glanzman;E. Mazzone;M. Main;M. Pelliccioni

  • Risdiplam in Type 1 Spinal Muscular Atrophy.

    Giovanni Baranello;Basil T Darras;John W Day;Nicolas Deconinck

Frequent Co-Authors

Francesco Muntoni
Francesco Muntoni University College London
Enrico Bertini
Enrico Bertini Bambino Gesù Children's Hospital
Claudio Bruno
Claudio Bruno Istituto Giannina Gaslini
Mary A. Rutherford
Mary A. Rutherford King's College London
Richard S. Finkel
Richard S. Finkel St. Jude Children's Research Hospital
Giacomo P. Comi
Giacomo P. Comi University of Milan
Caroline Sewry
Caroline Sewry Great Ormond Street Hospital
Volker Straub
Volker Straub Newcastle University
Giovanni Cioni
Giovanni Cioni University of Pisa
Darryl C. De Vivo
Darryl C. De Vivo Columbia University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in working in medicine but prefer flexible learning, there are several affordable online programs to consider. These options provide quicker entry points to healthcare-related careers or allow current professionals to advance their qualifications while working.

For those who enjoy managing medical records and data, online RHIT degree programs can prepare you for roles in health information management. If you prefer a behind-the-scenes role, medical billing and coding online courses are ideal for quickly gaining the specialized skills needed in clinics, hospitals, and billing agencies.

Nurses looking to advance can find accredited and cheapest online acute care nurse practitioner programs, providing graduate-level training for greater responsibility and higher salaries. Similarly, registered nurses seeking a bachelor's degree should explore the cheapest RN to BSN online pathways to boost career prospects without the need to pause their employment.

Each of these online degrees offers a flexible, affordable route to a rewarding healthcare career, suited to your goals and current experience level.

Best Scientists Citing Eugenio Mercuri

Trending Scientists

Recently Published Articles